(LifeSiteNews) — The Department of Justice must investigate abortion drug giant Danco Laboratories, Senator Josh Hawley (R-MO) says.

Last week, the Republican senator sent a letter to Acting Attorney General Todd Blanche “urging the Department of Justice to open an investigation into Danco Laboratories,” according to a news release from Hawley’s office.

Danco is “the manufacturer of the dangerous chemical abortion drug that has harmed thousands of women and ended the lives of countless unborn children.”

Hawley questioned whether Danco follows all laws and asked the Justice Department to look into the company’s “original FDA approval, ongoing regulatory compliance, manufacture and distribution pipeline, potentially deceptive marketing practices, and disclosure of safety risks pertaining to the company’s sole product—the chemical abortion drug, mifepristone.”

The senator opened his own investigation and raised concerns about the company’s operations.

He stated:

Very little information is publicly available about Danco Laboratories. The company first introduced mifepristone in the United States in 2000 and, in doing so, appears to have taken unusual and extreme measures to protect itself from liability…Yet Danco is profiting at the expense of women who have taken the drug and been seriously harmed by it.

The largest study of mifepristone ever conducted found that nearly 11% of women who take the drug experience a ‘serious adverse health event,’ such as sepsis or hemorrhaging. That rate amounts to 22 times higher than what Danco admits to on its label.

The investigation is particularly urgent, Hawley said, because women use abortion drugs nearly 70 percent of the time when they kill their babies.

“The American public demands answers to the chemical abortion drug that is flooding into every corner of the country—often contrary to state laws—and causing devastating harm to women and babies,” Hawley wrote. “I await your response confirming the initiation of your investigation.”

The DOJ responded to a request for comment from Fox News and claimed Trump had an “unmatched” record on defending human life.

READ: 78 pro-life groups urge Trump DOJ to reverse ‘harmful’ defense of abortion pills

“President Trump’s record on protecting unborn life and defending women’s health is unmatched,” an unidentified spokesperson told Fox News.

The statement continued:

The Department of Justice will continue to advance those priorities by asking courts to allow the FDA to complete its review of mifepristone safety data and by investigating any person or entity that engaged in illegal conduct putting women or unborn children at risk.

Danco Laboratories did not respond to a LifeSiteNews request for comment last week about Hawley’s allegations.

Trump has mixed record on abortion, causing concern among pro-life leaders

In contrast to claims by the DOJ, Trump has a mixed record on abortion.

As president, he restored the Mexico City Policy, which forbids taxpayer dollars from going to foreign nonprofits that kill innocent babies in the womb.

He also signed a temporary defunding of some abortion vendors, including Planned Parenthood.

On the other hand, he has not taken the strong actions on abortion drugs as many pro-life groups have urged him to do.

For example, abortion drugs continue to flood the country due to a relaxation of safeguards under the Biden administration. California and New York have explicitly said they will not assist pro-life states in prosecuting rogue abortionists who ship the deadly drugs in violation of state law.

While Louisiana’s attorney general and other pro-life attorneys have filed lawsuits to stop the practice and to try to get the federal government to intervene, the Trump administration has sided largely with the abortion industry.

In January, the Department of Justice asked a federal court to at least temporarily deny relief to Louisiana and Rosalie Markezich, who says her boyfriend pressured her into taking abortion drugs he received in the mail.

The DOJ argued the lawsuit would harm the safety review that has been promised since the beginning of the Trump administration.

The Trump administration also approved a new generic abortion drug, despite the alleged safety review that may or may not be underway.

These actions led nearly 80 pro-life groups to call on the Justice Department to protect women and innocent babies from the deadly chemicals.

The letter stated in part:

Pro-life states cannot meaningfully enforce their laws when FDA is siding with mail-order abortionists and DOJ is siding with abortion drug manufacturers.

Virtually every state has some law on the books that makes the current mail-order abortion regime unlawful, even basic laws like practicing medicine without a license. Yet abortionists protected by so-called ‘shield laws’ ship drugs nationally with impunity, pointing to FDA for cover. Despite firm commitments from HHS Secretary Kennedy and FDA Commissioner Makary to conduct a thorough safety review of abortion drugs, FDA subsequently expanded the availability of the abortion drug mifepristone by approving a new generic version last fall.

Signers included Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, John Mize, president of Americans United for Life, and a slew of state-level pro-life and pro-family groups.